Skip to main content

DEFINIENDO MECANISMOS DE ACOPLAMIENTO ENTRE TRANSCRIPCION Y SPLICING VINCULADOS A ENFERMEDADES DEGENERATIVAS

BFU2017-89179-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Improved synthesis and characterization of cholesteryl oleate-loaded cationic solid lipid nanoparticles with high transfection efficiency for gene therapy applications

  • Suñé-Pou, Marc
  • Limeres, María J.
  • Nofrerias, Isaac
  • Nardi-Ricart, Anna
  • Prieto-Sánchez, Silvia
  • El Yousfi, Younes
  • Pérez-Lozano, Pilar
  • García-Montoya, Encarna
  • Minarro-Carmona, Montserrat
  • Ramón Tico, Josep
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
  • Suñé-Negre, Josep Mª
The development of new nanoparticle formulations that are capable of high transfection efficiency without toxicity is essential to provide new tools for gene therapy. However, the issues of complex, poorly reproducible manufacturing methods, and low efficiencies during in vivo testing have prevented translation to the clinic. We have previously reported the use of cholesteryl oleate as a novel excipient for solid lipid nanoparticles (SLNs) for the development of highly efficient and nontoxic nucleic acid delivery carriers. Here, we performed an extensive characterization of this novel formulation to make the scale up under Good Manufacturing Practice (GMP) possible. We also describe the complete physicochemical and biological characterization of cholesteryl oleate-loaded SLNs to ensure the reproducibility of this formula and the preservation of its characteristics before and after the lyophilization process. We defined the best manufacturing method and studied the influence of some parameters on the obtained nanoparticles using the Quality by Design (ICH Q8) guideline to obtain cholesteryl oleate-loaded SLNs that remain stable during storage and guarantee in vitro nucleic acid delivery efficacy. Our results indicate that this improved formulation is suitable for gene therapy with the possibility of scale-up the manufacturing of nanoparticles under GMP conditions., We are grateful to many colleagues for their helpful suggestions, critical discussions, and comments. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2017-89179-R) and the Andalusian Government (Excellence Project BIO-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2016-79699-P) to C.H.M. Support from the European Region Development Fund (ERDF [FEDER]) is also acknowledged. M.S.-P. was supported by a fellowship from the Spanish Ministry of Education (FPU Program)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role for the splicing factor TCERG1 in Cajal body integrity and snRNP assembly

  • Moreno-Castro, Cristina
  • Prieto-Sánchez, Silvia
  • Sánchez-Hernández, Noemí
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
Este artículo ha sido seleccionado para su inclusión en la sección “Research Highlights” de la revista., Cajal bodies are nuclear organelles involved in the nuclear phase ofsmall nuclear ribonucleoprotein (snRNP) biogenesis. In this study, weidentified the splicing factor TCERG1 as a coilin-associated factorthat is essential for Cajal body integrity. Knockdown of TCERG1disrupts the localization of the components of Cajal bodies, includingcoilin and NOLC1, with coilin being dispersed in the nucleoplasm intonumerous small foci, without affecting speckles, gems or the histonelocus body. Furthermore, the depletion of TCERG1 affects therecruitment of Sm proteins to uridine-rich small nuclear RNAs(snRNAs) to form the mature core snRNP. Taken together, theresults of this study suggest that TCERG1 plays an important role inCajal body formation and snRNP biogenesis., This work was supported by grants from the Spanish Ministry of Economy andCompetitiveness (Ministerio de Economı́a y Competitividad; grant numberBFU2017-89179-R to C.S. and grant number BFU2016-79699-P to C.H.M.) and theAndalusian Government (Excellence Project BIO-2515/2012) to C.S. Support fromthe European Region Development Fund [ERDF (FEDER)] is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Drosophila Prp40 localizes to the histone locus body and regulates gene transcription and development

  • Prieto-Sánchez, Silvia
  • Moreno-Castro, Cristina
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
In eukaryotes, a large amount of histones need to be synthesized during the S phase of the cell cycle to package newly synthesized DNA into chromatin. The transcription and 3' end processing of histone pre-mRNAs are controlled by the histone locus body (HLB), which is assembled on the shared promoter for H3 and H4 Here, we identified the Drosophila Prp40 pre-mRNA processing factor (dPrp40, annotated as CG3542) as a novel HLB component. We showed that dPrp40 is essential for Drosophila development, with functionally conserved activity in vertebrates and invertebrates. We observed that dPrp40 is fundamental in endocycling cells, highlighting a role for this factor in mediating replication efficiency in vivo The depletion of dPrp40 from fly cells inhibited the transcription, but not the 3' end processing, of histone mRNA in a H3- and H4-promoter-dependent manner. Our results establish that dPrp40 is an essential protein for Drosophila development that can localize to the HLB and might participate in histone mRNA biosynthesis., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad; BFU2014-54660-R and BFU2017-89179-R) and the Andalusian Government (BIO-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (BFU2016-79699-P) to C.H.M. S.P.-S. was supported by a contract from the Spanish Ministry of Economy and Competitiveness (Juan de la Cierva Program). Support from the European Region Development Fund [ERDF (FEDER)] is also acknowledged.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease

  • Suñé-Pou, Marc
  • Limeres, M.J.
  • Moreno-Castro, Cristina
  • Hernández-Munaín, Cristina
  • Suñé-Negre, Josep Mª
  • Cuestas, María L.
  • Suñé, Carlos
Alternative splicing of pre-mRNA contributes strongly to the diversity of cell- and tissue-specific protein expression patterns. Global transcriptome analyses have suggested that >90% of human multiexon genes are alternatively spliced. Alterations in the splicing process cause missplicing events that lead to genetic diseases and pathologies, including various neurological disorders, cancers, and muscular dystrophies. In recent decades, research has helped to elucidate the mechanisms regulating alternative splicing and, in some cases, to reveal how dysregulation of these mechanisms leads to disease. The resulting knowledge has enabled the design of novel therapeutic strategies for correction of splicing-derived pathologies. In this review, we focus primarily on therapeutic approaches targeting splicing, and we highlight nanotechnology-based gene delivery applications that address the challenges and barriers facing nucleic acid-based therapeutics., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2017-89179-R to CS and grant number BFU2016-79699-P to CH-M). Support from the European Region Development Fund (ERDF [FEDER]) is also acknowledged.